FDA Approves, Leqembi, New Treatment for Early Alzheimer’s



The drug, Leqembi, may modestly slow cognitive decline in early stages of the disease but carries some safety risks. Still, data suggests it is more promising than the small number of other available treatments.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Get free Amazon $100 gift cards